TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients
Condition: Acute Ischemic Stroke Intervention: Drug: IV tPA (Activase) Sponsors: Assiut University; Aswan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2022 Category: Research Source Type: clinical trials
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial
DiscussionThe best management of SMH is unknown. TIGER aims to establish if the benefits of SMH surgery outweigh the risks, relative to aflibercept monotherapy.Trial registrationClinicalTrials.govNCT04663750; EudraCT: 2020-004917-10. (Source: Trials)
Source: Trials - January 31, 2022 Category: Research Source Type: clinical trials
A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke Interventions: Drug: Tirofiban 0.05 MG/ML; Drug: 0.9% sodium chloride solution Sponsor: GrandPharma (China) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials
